RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer

NCT02502656 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 425

Last updated 2016-11-17

No results posted yet for this study

Summary

This study will evaluate the concordance of RAS mutation detection between the results obtained from circulating tumor DNA and those obtained with the "standard" method (testing from tumor tissue).

Conditions

Sponsors & Collaborators

  • Association des Gastroentérologues Oncologues

    lead OTHER

Principal Investigators

  • Jean-Baptiste Bachet, Dr · Association des Gastro-entérologues Oncologues (AGEO)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02502656 on ClinicalTrials.gov